UroGen Pharma Market Cap

UroGen Pharma has a market cap or net worth of 339.48 million as of February 21, 2025. Its market cap has decreased by -13.54% in one year.

Market Cap

339.48M

Enterprise Value

235.48M

Revenue

66.67M

Ranking

n/a

PE Ratio

n/a

Stock Price

10.52

Market Cap Chart

Since May 4, 2017, UroGen Pharma's market cap has increased from 129.71M to 339.48M, an increase of 161.73%. That is a compound annual growth rate of 13.11%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	339.48M	-5.43%
Dec 31, 2024	358.99M	-1.24%
Dec 29, 2023	363.49M	113.84%
Dec 30, 2022	169.98M	7.95%
Dec 31, 2021	157.47M	-46.00%
Dec 31, 2020	291.60M	-44.84%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	179.71B
Shell	161.28B
HSBC Holdings	157.51B
Unilever	110.61B
Rio Tinto Group	86.77B
RELX PLC	72.31B
BP p.l.c.	70.06B
British American Tobacco p.l.c.	65.18B

Market Cap Rankings